SIME 2025 – Healthspan vs Lifespan | 16 May 2025 – Milan

SEFFILINE is a leading company in the field of devices for Autologous Regenerative Therapy in the outpatient setting, for sure one of the most innovative therapies in many medical specialties such as Aesthetic Medicine, Trichology and Gynecology. We are pleased to share this vision with Esteemed Professionals who will present their experience on Autologous Regenerative Therapy (ART) at the SIME 2025 Congress.